Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice.

Panoskaltsis-Mortari, A

Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice. [electronic resource] - Blood Nov 1998 - 3960-7 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0006-4971


Animals
Bone Marrow Transplantation--adverse effects
Cyclophosphamide--administration & dosage
Digestive System--pathology
Drug Evaluation, Preclinical
Fibroblast Growth Factor 10
Fibroblast Growth Factor 7
Fibroblast Growth Factors
Graft vs Host Disease--etiology
Growth Substances--administration & dosage
Lung--pathology
Mice
Mice, Inbred C57BL
Premedication
Radiation Chimera
Recombinant Fusion Proteins--administration & dosage
Skin--pathology
Specific Pathogen-Free Organisms
Transplantation Conditioning--adverse effects
Transplantation, Homologous
Whole-Body Irradiation--adverse effects